| Abstract | Polovica uključenih ispitanika bila je mlađa od 5,1 godinu, a podjednako su zastupljena oba spola (35, 50% djevojčica naspram 35, 50% dječaka). Nije bilo statističke razlike u dobi između muških i ženskih ispitanika (4 naspram 5,6 godina, p=0,977). Kumulativna incidencija hospitalizacija svih ispitanika iznosi 53,24 na 100000 stanovnika (95% CI 41,5-67,2), odnosno 54,21 na 100000 (95% CI 37,8-75,4) u ženskih ispitanika i 52,30 (95% CI 36,4-72,7) u muških ispitanika. Najveća incidencija ES-a je u dobi 0-4 godine koja je značajno veća u odnosu na više dobne skupine. Dječaci i djevojčice se nisu statistički značajno razlikovali prema komplikacijama u trudnoći (p=0,113), porodu (p=0,282) i ranom perinatalnom periodu (p=0,611) te Apgar zbiru (p=0,592). Nema značajne razlike u trajanja napadaja prema kliničkoj slici (p=0,146), broju napadaja (p=0,225), prvih u odnosu na ponovljene napadaje (p=0,594), terapiji prije prijema (p=0,418), terapiji na prijemu (p=0,163), Apgar zbiru (p=0,283), psihomotornom razvoju (p=0,529) i ponovljenoj terapiji (p=0,629). Ipak, postoji razlika duljine trajanja epileptičkog statusa s obzirom na terapiju koja zaustavlja status (p<0,001). Postoji statistički značajna razlika u trajanju ES između različitih etiologija (p=0,025). |
| Abstract (english) | Half of the included respondents were younger than 5.1 years, and both sexes were equally represented (35, 50% girls vs. 35, 50% boys). There was no statistical difference in age between male and female subjects (4 vs. 5.6 years, p=0.977). The cumulative incidence of hospitalizations of all subjects was 53.24 per 100,000 population (95% CI 41.5-67.2), or 54.21 per 100,000 (95% CI 37.8-75.4) in female subjects and 52.30 (95% CI 36.4-72.7) in male subjects. The highest incidence of ES is at the age of 0-4 years, which is significantly higher compared to higher age groups. Boys and girls did not differ statistically significantly according to complications in pregnancy (p=0.113), childbirth (p=0.282) and early perinatal period (p=0.611) and Apgar score (p=0.592). There is no significant difference in the duration of seizures according to the clinical picture (p=0.146), the number of seizures (p=0.225), the first in relation to recurrent seizures (p=0.594), therapy before admission (p=0.418), therapy on admission (p=0.163), Apgar score (p=0.283), psychomotor development (p=0.529) and repeated therapy (p=0.629). However, there is a difference in the duration of status epilepticus with respect to status-stopping therapy (p<0.001). There is a statistically significant difference in the duration of ES between different etiologies (p=0.025). |
